Qiagen is interested in organic growth and acquisitions – CEO According to analysts, these improvements are "important" and make Qiagen less likely to see a sharp post-COVID-19 share price…
Virus testing M&A fails smell test The $10 billion Quidel specialises in infectious diseases diagnostics while Qiagen mainly makes genetic testing kits, meaning few…
